Results 181 to 190 of about 24,384 (198)

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, Matthew D Galsky, William K Oh   +2 more
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Elizabeth A Mittendorf, Gabriel N Hortobagyi   +1 more
exaly  

Targeting receptor complexes: a new dimension in drug discovery

Nature Reviews Drug Discovery, 2020
Mette Ishøy Rosenbaum, Louise Albertsen, David S Bredt   +2 more
exaly  

New Molecular Classifications of Breast Cancer

Ca-A Cancer Journal for Clinicians, 2009
William Gradishar
exaly  

Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes

Nature Reviews Drug Discovery, 2011
Uwe Rudolph
exaly  

Development of subtype-selective oestrogen receptor-based therapeutics

Nature Reviews Drug Discovery, 2011
Konrad F. Koehler, Jan-Ake Gustafsson
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Manuel Picón Ruiz, Joyce M Slingerland   +2 more
exaly  

Targeting pathological B cell receptor signalling in lymphoid malignancies

Nature Reviews Drug Discovery, 2013
Ryan M Young, Louis M Staudt
exaly